CJC-1295 DAC 2MG

Nano Peptides CJC-1295 DAC 2 mg is a high-purity, lyophilized research peptide studied for its long-acting interaction with the GHRH receptor, supporting investigations into growth-hormone pulse dynamics, IGF-1 pathway signaling, and recovery/adaptation after intense training. The DAC (Drug Affinity Complex) allows albumin binding in models, extending activity and enabling researchers to examine sustained GH rhythms rather than short spikes. In bodybuilder-relevant research, this helps map how protein synthesis, tissue remodeling, fat metabolism, and sleep-linked recovery may correlate with prolonged GH signaling strictly within experimental contexts.

Each vial contains 2 mg CJC-1295 DAC (≥99% HPLC) as a white, freeze-dried powder in a 10 mL research vial. In laboratory workflows, investigators typically reconstitute lyophilized peptides with a sterile aqueous medium (e.g., bacteriostatic water or sterile 0.9% saline) using aseptic technique, allow gentle swirling until dissolved, and store the reconstituted sample refrigerated per institutional SOPs for short-term bench work. This listing does not include dosing or administration guidance; it clarifies that the peptide is supplied dry and is intended to be dissolved for cell/tissue assays or approved animal models.

In skeletal-muscle models, prolonged GHRH-receptor stimulation is studied for links to pulsatile GH release, which downstream may influence IGF-1 signaling, protein synthesis, and soft-tissue remodeling mechanisms relevant to post-training recovery. Connective-tissue investigations evaluate markers tied to collagen turnover and tendon/ligament integrity, while metabolism studies explore lipolysis, nutrient partitioning, and body-composition endpoints under extended GH signaling. Sleep-recovery research tracks how night-time GH pulses relate to restorative processes after high-volume blocks. Collectively, these lines of inquiry help performance researchers understand how sustained GH secretagogue activity may shape readiness, durability, and adaptation without making medical claims or suggesting human use.